Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear Microscopy

NCT: NCT02926729 · TERMINATED

NCT IDNCT02926729
StatusTERMINATED
Start Date2019-07-17
Completion2025-07-14
SponsorBeth Israel Deaconess Medical Center (OTHER)
First posted
Last updated

Brief Summary

This research is studying a new investigative imaging instrument called a nonlinear microscope (NLM). A nonlinear microscope can produce images similar to an ordinary pathologist's microscope, but without first processing tissue to make slides. This study will determine if a NLM can be used to evaluate tissue during lumpectomy surgery for breast cancer in order to reduce the probability that standard pathologic examination of the specimen after the end of the operation will find close or positive margins, thus possibly requiring the patient to have additional breast surgery.

Frequently Asked Questions

What is Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear Microscopy?

Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear Microscopy is a clinical trial registered under NCT02926729. Current status: TERMINATED.

What is the status of NCT02926729?

The current status of NCT02926729 (Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear Microscopy) is: TERMINATED.

When did Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear Microscopy start?

Real-Time Assessment Of Breast Cancer Surgical Specimen Margins With Nonlinear Microscopy started on 2019-07-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.